Theme: New approaches in Diabetes care and Prevention

Diabetes Global 2016

Renowned Speakers

Diabetes Global 2016

Track 1: Anatomy and physiology of diabetes

Pathophysiologic modification is a change in task as notable from a structural defect. Diabetes occurs when there is a dis-balance between the demand and manufacture of the hormone insulin. Pathophysiology of diabetes is that in this circumstance the immune system outbreaks and terminates the beta cells of the pancreas which produce insulin. There is lack of beta cell leading to complete insulin deficiency. Whereas in type 2 diabetes there is comparatively lesser deficiency of insulin and not an complete deficiency. This means that the body is incapable to harvest appropriate insulin to overcome the demand. There is Beta cell deficiency coupled with peripheral insulin resistanceGestational diabetes is the third type of diabetes. It is caused when there are excessive counter-insulin hormones of pregnancy. This paves the way to a state of insulin resistance and high blood sugar in the mother. There may be faulty insulin receptors. These part of diabetes study is covered in ADA meetings and IDF word Diabetes Congress

Related Diabetes conferences | Endocrinology Conferences| Conferences Series LLC

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA;8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015,India;  Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico, Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 2: Clinical and diagnostic approaches

Diabetes may be analysed based on both plasma glucose criteria or  A1C criteria. Early in disease diabetes shows no symptoms so blood tests are used to diagnose diabetes and pre-diabetes. Clinical diagnostic in diabetes involve taking blood at a healthcare facility centre or commercial diagnostic centre and sending the sample to a lab for examination. To ensure that test results are accurate lab study of blood of required. Glucose calculating devices used in a health care provider’s office, such as finger-stick devices, are not precise enough for analysis but may be used as a rapid indicator of high blood sugar. Such area of research are highle discussed in  ADA annual meeting  and ADA sessions

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada;11th Asia Pacific, Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK;  International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK 

Track 3: Diabetes Case Studies

Diabetes case reports are in-depth inquiries of an individual, crowd, occasion or public. The data are assembled from a diversity of places by various methods.The case study technique encompasses spotting what happens to, or reconstructing ‘the case history’ of a single participant or group of individuals, i.e the idiographic approach. Case studies permits an investigator to investigate a topic in far more detailed and minute way.The case study is not itself a research method, but investigators choose methods of data collection and analysis that will generate material suitable for case studies. Most of this evidence is likely to be qualitative but the psychologist might collect numerical data as well and present in various diabetes conference and scientific sessions

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 15- September 17, Berlin, Germany, 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016,USA ; 11th Asia Pacific Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE;15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE;11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016, Malaysia; Mid-Atlantic AACE 13th Annual meeting on Endocrinology Sep 25-26 2015, USA; AACE New England annual meeting on endocrinology November 14th 2015, Marlborough; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Endocrinology Conferences October 10-12, 2016 Manchester, UKObesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 4: Symptoms, prevention and treatment of diabetes

Diabetes is a severe illness that cannot be cured of its own. Doctor aids to create a diabetes management plan that is right for the patient. Cure for diabetes demands to keep close watch over the blood sugar level with a combination of medications, work out, and diet. Since the spectacular finding in Toronto in 1922 that type 1 diabetes arises from a deficit of insulin. Research on Insulin is extensively discussed in National Diabetes Conference and Diabetes associations.The supervision of diabetes has been decisively grounded in scientific advances that endure to outline our understanding of the pathophysiology of diabetes  and direct our choices in choosing optimal therapies for type 1 and type 2 diabetes. Now, a days we get in market glucose meters which is a modern technology which has the capability to help people living with type 1 or type 2 diabetes and treated with insulin to accomplish the dream of ideal control of blood sugar.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 15- September 17, Berlin, Germany, 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA; Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; New Therapeutics for Diabetes and Obesity April 17-20, 2016 USA; International Conference on Diabetes Mellitus September 18-20 2015, China; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016; ;  International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK, Obesity Conferences Nov 14-15, 2016 Dubai, UAE

Track 5: Diabetes in Market

Diabetes trade directs to the 11 largest therapeutic and diagnostic companies producing diabetes related merchandises or those involved with to take diabetes cure to next level. Diabetes is a major issue in the UK, and as such a large healthcare and medical industry has come up like mushroom around it. Aspects such as growing number of diabetic patients across BRIC countries, increasing study on diabetes, and increasing international research collaborations are lashing the growth of the this market. In the European Region there is about 60 million people leaving with diabetes, or about 10.3% of men and 9.6% of women aged 25 years and over. Occurrence of diabetes is growing among all ages in the, typically due to escalations in overweight and obesity, unhealthy diet and less of physical activity.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA;8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015,India;  Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico, Endocrinology Conferences October 10-12, 2016 Manchester, UK 

Track 6: Complementary and Alternative Medicine and Therapies

Complementary and alternative medicine is can be well-defined as a "cluster of varied therapeutic and health care arrangements, practices, and medicines that are not presently measured to be part of predictable medicine”. Complementary medicine is used with predictable therapy, whereas alternative medicine is used instead of conventional medicine. In CAM therapies diabetes supplement is widely given to the diabetic patients in. Although some of these therapies may be useful, others can be not so useful or even harmful. Contrary reactions of many CAM therapies are not well known because patients with diabetes often take various diabetes medications, there occurs budding for herbal medicine and herb dietary habit supplement interactions, leading to contrary events.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada;11th Asia Pacific, Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK;  International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK 

Track 7: Biomarker: Diagnostic tool for Diabetes

Molecular Biomarkers can be demarcated as “a characteristic that is accurately measured and gauged as an pointer of normal biological procedures, pathogenic procedures, or pharmacologic responses to a pharmaceutical intervention. Biomarkers play an vital part in leading clinical trials and treating patients. Advances in molecular diagnostics help medical professionals make knowledgeable, scientifically valid decisions. More well-organized discovery and usage of biomarkers in the growth of antidiabetes drugs will depend on accelerating our understanding of the pathogenesis of diabetes and specifically its macrovascular complications.  Procedural improvements from other fields, especially cancer, are beginning to show the way towards better models of diabetes pathogenesis and molecular biomarker discovery.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada;11th Asia Pacific, Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK;  International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK 

 Track 8: Endocrinology: Disorder and Treatment

Clinical Endocrinology and metabolism is a field of medicine; more precisely a sub-specialty of internal medicine, which mainly deals with the investigation and management of sicknesses related to hormones. The human endocrine system involves number of glands. These glands harvest and release hormones which monitors many important function of our body. When the hormones exits the glands they arrive the bloodstream and are moved to organs and tissues in every part of the body. Endocrinology also concentrates on the endocrine glands and tissues that secrete hormones. The human endocrine system comprises of several glands. These glands harvest and secrete hormones which regulates the body's metabolism, growth, sexual development and function. Hormonal imbalance in our body henceforth leads to diabetes.  

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 15- September 17, Berlin, Germany, 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016,USA ; 11th Asia Pacific Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE;15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE;11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016, Malaysia; Mid-Atlantic AACE 13th Annual meeting on Endocrinology Sep 25-26 2015, USA; AACE New England annual meeting on endocrinology November 14th 2015, Marlborough; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Endocrinology Conferences October 10-12, 2016 Manchester, UKObesity Medicine Conferences Nov 14-15, 2016 Dubai, UAE

Track 9: Diabetes and its Complications

Long-standing complications of diabetes grow progressively. Number of years of having diabetes is directly proportional to the higher risk of complications. Sometimes diabetes complications may be restricting or even lethal. A well-controlled blood sugar have less diabetic complications.  Broader health issues quicken the venomous effects of diabetes which include smoking, higher diabetes cholesterol levels, obesity, high blood pressure, and lack of regular exercise. The best forecaster of type 2 diabetes is overweight or obesity. People who have weight related issues or have obesity have additional pressure on their body's capability to use insulin to properly control blood sugar levels, and are therefore pick up diabetes more easily.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA;8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015,India;  Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico, Endocrinology Conferences October 10-12, 2016 Manchester, UK 

Track 10: Diabetes and Associated Diseases

Diabetes intensifies the danger of long-term complications. Diabetes increases the risk of cardiovascular diseases such as diabetic cardiomyopathy. The chief complications of diabetes due to injury in small blood vessels comprise damage to the eyes, kidneys, and nerves. Damage to the eyes is known as diabetic retinopathy which is triggered by damage to the blood vessels in the retina of the eye leading to diabetic eye complications. Damage to the kidneys, known as diabetic nephropathy, can pave the way to tissue damaging, urine protein damage, and eventually dibetic nephropathy disease. Diabetes is one of the main cause of kidney failure. At least two third of the people with diabetes may have signs of onset of kidney problems at early stage. Damage to the nerves of the body, known as diabetic neuropathy, is the most common complication of diabetes.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada;11th Asia Pacific, Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK;  International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK 

Track 11: Genetics and Transplantation of Diabetes

Metabolic syndrome and related metabolic traits heritability is relatively high. Genetically altered knockout mice models and human monogenic obese/insulin unaffected syndrome deliver significant molecular insights into the pathogenesis of the metabolic syndrome. Transfer (engraftment) of human cells, tissues or organs from a donor to a recipient with the aim of restoring function in the body is called as transplantation. It can be of various types such as pancreas transplantation, xenotransplantation and islet transplantation.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA;8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015,India;  Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico, Endocrinology Conferences October 10-12, 2016 Manchester, UK

Track 12: Therapy for Diabetes and its Complications

Cell therapy can be explained as the supervision of live whole cells or maturation of an exact cell population in a patient to overcome the disease. Cell therapy is growing its range of cell types for administration. The treatment strategies of cell therapy comprise separation and transmission of specific stem cell populations, administration of effector cells, induction of mature cells to develop pluripotent cells, and reprogramming of mature cells. The founding of pluripotent human embryonic stem cells and embryonic germ cells have presented a new probable source in type 1 diabetic patients for cell therapy, especially in light of recent successes in generating glucose-sensitive insulin-secreting cells from mouse embryonic stem cells.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada;11th Asia Pacific, Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK;  International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK 

Track 13: Market analysis of Diabetic products

Diabetes care market encompasses of technologies, devices and therapeutics in relative to diabetes. There has been a substantial increase in the amount of diabetes cases internationally over the last few years. Currently, about millions of people are in misery because of obesity, which is a key reason for increase of diabetes in people. Key Players profiled in the report include Glaxosmithkline, Novo Nordisk, Roche, Medtronicand etc. Novo Nordisk is a leading global provider of diabetes products. The company also has a headship spot in hemostasis management, growth hormone therapy and hormone replacement therapy. The company progresses, manufactures and markets its medical devices and technologies to hospitals, doctors, researchers, scientists and patients in approximately 160 countries. 

 Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

Diabetes Conferences, September 29- October 01, Berlin, Germany, Canada;11th Asia Pacific, Diabetes Conference and Expo July 11-13 2016,Australia; 6th Global Diabetes Summit and Medicare Expo November 02-04 2015, UAE; 15th Global Diabetes Summit and Medicare Expo November 14-16 2016, UAE; International Conference on Targeting Diabetes and Novel Therapeutics September 14-16 2015,USA; The 5th World Congress on Controversies to Consensus in Diabetes, Hypertension and Obesity November 05-07, 2015,Turkey; 43rd Meeting of the British Society for Paediatric Endocrinology and Diabetes November 25-27 2015, UK; , European Association for the Study of Diabetes Eye Complications Study Group 26th Annual Meeting June 16-18 2016, UK;  International Conference on Metabolic Syndromes October 20-22, 2016,UAE, Obesity Medical Conferences  Nov 14-15, 2016 Dubai, UAE, Endocrinology Conferences October 10-12, 2016 Manchester, UK 

Track 14: Emerging Focus in Diabetes Research

Diabetes throws a light in a growing epidemic imposing thoughtful social economic crisis around the nation. Despite scientific innovations and better healthcare research amenities the disease continues to burden numerous segments, especially middle and low income countries. The current trends designate the rise in premature death, posing a major threat to global development. The advancement in science and technology have observed the expansion of newer generation of nanomedicine in drugs discovery. Then, the documentation and clinical investigation of bioactive ingredients from plants have transformed the investigation on drug discovery and lead identification for diabetes management control.

Related Diabetes conferences | Endocrinology ConferencesConferences Series LLC

11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics October 17-19 2016,Malaysia; 9th Global Diabetologists Annual Meeting and Medicare Expo June 06-08 2016, USA;8th Euro Global Diabetes Summit and Medicare Expo November 03-05 2015, Spain; Diabetes Conferences, September 15- September 17, Berlin, Germany; 7th Indo Global Diabetes Summit and Medicare Expo November 23-25, 2015,India;  Physiology, pathophysiology and future treatment options for diabetic complications December 7 2015,UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; 18th International Conference on Diabetes and Immunology May 23-24 2016, UK; Pediatric endocrine society annual meeting April 29 2016, USA; Obesity and Adipose Tissue Biology February 15-19 2016, Canada; ISN World Congress of Nephrology April 21-25 2017, Mexico, Endocrinology Conferences October 10-12, 2016 Manchester, UK

Omics International Conference appeals all the participants from all around the nation to attend '13th Global Diabetes and Medicare Expo' which is going to be held in August 08-10, 2016 at Birmingham, UK which includes highly expertise key note panel, oral and poster presentation and exhibitions by the leading companies of diabetes

Diabetes Global 2016 is devoted to “New approaches in Diabetes care and prevention”. Diabetes is globally familiar as one of the foremost causes of death and incapacity in the United States. In 2000, it was the sixth chief cause of death. About 65% of deaths within people living with diabetes are attributed to stroke and heart disease. Diabetes is related with long-term complications that affect almost each and every part of the body. Unrestricted diabetes can confuse pregnancy, and birth flaws are more common in babies born to women with diabetes. 

 

                                              Scope and Importance of Diabetes

Diabetes is globally familiar as one of the foremost causes of death and incapacity in the United States. In 2000, it was the sixth chief cause of death. About 65% of deaths within people living with diabetes are attributed to stroke and heart disease. Diabetes is related with long-term complications that affect almost each and every part of the body. Unrestricted diabetes can confuse pregnancy, and birth flaws are more common in babies born to women with diabetes. The task of the International Diabetes Federation is to encourage diabetes care, prevention and a cure worldwide. Clinical trials are an vital step in our being able to have new treatments for diabetes and other conditions.

                                                   Why Birmingham (UK)?

The number of people diagnosed with diabetes in the UK has increased to more than 3.2 million, according to figures released by Diabetes UK. The new figures demonstrate that the sharp rise in people with diabetes seen in the UK over the last decade shows no sign of decelerating down. New figures show that Birmingham has the maximum rate of diabetes in the country, with nearly one in 10 people in some parts of the UK's second largest city living with disease.

                                     Societies associated with diabetes research

To inspire, educate, apprise and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Diabetes various well-known societies/associations are working across the world to professionally avoid and combat the lethal disease

Major diabetes association in UK:

·         British Diabetic association

·         Diabetes UK

·         Association of British Clinical Diabetologists

·         British Society for Paediatric Endocrinology and Diabetes

Major diabetes association in Europe:

·         European association for the study of diabetes

·         European diabetes foundation

·         Diabetes Association Switzerland

·         Spanish Diabetes Society (Spain)

·         Swedish Diabetes Association

Major diabetes association in USA:

·         American Diabetes Association

·         American Association of Clinical Endocrinologists

·         Centre for Disease Control: Division of Diabetes Translation

·         Diabetes Advocacy Alliance

·         Diabetes Hands Foundation

·         Juvenile Diabetes Foundation International

·         National Kidney Foundation

·         National Institute of Diabetes and Digestive and Kidney Diseases

Major Diabetes Associations around the Globe:

·         Diabetes Indian Association

·         Canadian Diabetes Association

·         International Diabetes Federation

·         Diabetes Australia

·         Austrian Diabetes Association.

·         Diabetes South Africa

·         Asia diabetes foundation

·         Asian association for the study of diabetes

·         Korean Diabetes Association

                                         

                                                Market research on diabetes                    

Diabetes industry guides to the 11 largest pharmaceutical and diagnostic companies producing diabetes related products or those involved with diabetes research. Diabetes is a major problem in the UK, and as such a large healthcare and treatment industry has built up around it.Diabetes care devices market is estimated to grow at a CAGR of 6.3% from 2015 to 2020, to reach USD 2.3 Billion by 2020 from USD 1.7 Billion in 2015. Factors such as increasing number of diabetic patients across BRIC countries, growing research on diabetes, and increasing international research collaborations are driving the growth of the this market. Rising obese population and lifestyle changes (driving the prevalence of diabetes among the urban population) are further contributing to the growth of this market. However, high cost of diabetes care devices, disparity in reimbursement, availability of alternative treatments, and lack of awareness are restraining the growth of this market.

                                                  Global prevalence of diabetes

One in 10 people globally will have diabetes by 2035, according to a concerning new report.To highlight World Diabetes Day which takes place each year on Nov. 14, the International Diabetes Federation (IDF) released its sixth edition of the Diabetes Atlas. The report estimates how many adults between the ages of 20 to 79 will be affected by the disease in the future. By the end of this year, the IDF estimates that 382 million people will have diabetes around the world. By 2035, that number will skyrocket to 592 million. For comparison, about 285 million people had the disease just four years ago. Eighty percent of people with the disease live in low- and middle-income countries, and most of them are between 40 and 59 years old. The organization also said that one person dies from diabetes every six seconds, or about 5.1 million deaths annually.

                                             

Diabetic Medications-2015

 

The International Conference on Targeting Diabetes and Novel Therapeutics (Diabetic Medications-2015) convoked by OMICS International during September 14-16, 2015 was successfully held at Embassy suites Las Vegas, Nevada, USA with a theme “New insights in prevention and management of diabetes through intervening technologies” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

The pragmatic meet organized by OMICS International brought together a group of Diabetologists, Endocrinologists Clinicians, Young Researchers and Industry Representatives from across the globe with interest and expertise in the field of diabetes research. The conference marked the successful gathering of eminent speakers from various reputed organizations driving the three day event into the path of success and their regnant talks enlightened the gathering.

Diabetic Medications-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Fawad Javed, University of Rochester, USA who contributed a lot for the smooth functioning of this event.

Our special thanks to Dr. Osman Amine El-Labban, Al Zahra Private Hospital, UAE, for his special participation in the workshop titled “Role of a Preventive National Program in Combating Diabetes Mellitus & Cardiovascular Diseases” which marked the special attraction at the conference.

Diabetic Medications-2015 extends its warm gratitude to all the Honorable Guests and Keynote Speakers of the event:

Dr. Patrick G Sullivan, University of Kentucky, USA

Dr. Fawad Javed, University of Rochester, USA

Dr. Anil K Mandal, University of Florida, USA

Dr. Maria Faresjo, Jonkoping University, Sweden

Dr. Christain Dani, French National Institute for Health and Medical Research, France

Dr. Osman Amine El-Labban, Al Zahra Private Hospital, UAE

Dr. Khalid Alnemer, AL-Imam University, Kingdom of Saudi Arabia

Dr. Mohamed El-Far, Mansoura University, Egypt

Diabetic Medications-2015 conference congratulates the Best Poster Awardee Mr. Parth Rajput, Nirma University, India for his outstanding performance and appreciates all the participants who put their research at poster presentations and sincerely wish them every success in their future endeavors. Also, we would like to thank the Poster Competition Judge Dr. Emmanuel Mukwevho, North West University, South Africa for his valuable support and advice.
 

OMICS International is privileged to felicitate Diabetic Medications-2015 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. OMICS International would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Diabetes.

With the valuable feedback received from the participants of Diabetic Medications-2015, OMICS Group is glad to announce the commencement of “11th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics” to be held during October 17-19, 2016 in Kaula Lampur, Malaysia. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of managing diabetes and its concomitant risk factors.


Past Reports  Gallery  

Diabetes 2014
 
 
The 5th World Congress on Diabetes & Metabolism, hosted by the OMICS Group was held during November 03-05, 2014 at Embassy Suites Las Vegas, USA with the theme “To translate and harness novel therapies in diabetes". This one-stop meeting provided comprehensive updates, education, and information on current and emerging diabetes patient management issues and challenges.The Conference was accomplished by the support of diabetes specialty physicians, podiatrists, students, physician assistants, professors, assistant, professors, enterpreneurs, nurse practitioners, nurses, dietitians, certified diabetes educators, delegates and other health care professionals representing more than 25 countries, who made this conference fruitful and productive.
 
We are also thankful to the following exhibitors for their participation and interactive sessions:
 
Sable Systems International, Inc., USA
ABC Trading Solutions, USA
The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:
 
Clinical Diabetes and Diagnostic Approaches
Diabetes Management
Diabetes and its Complications
Advanced Technologies for Treatment of Diabetes
Advancement of New Drug/Biomarker Discovery for Treatment of Diabetes
Genetics of Diabetes
Emerging Focus in Diabetes Research
Transplantation for Diabetes
Endocrinology: Disorders & Treatment
 
 
OMICS International would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers of Diabetes-2014:
 
Sayon Roy, Boston University, USA
Zhengyuan Xia, University of Hong Kong, China
Ippei Kanazawa, Shimane University, Japan
Premanidhi Panda, Dr. Panda Diabetes Institute, India
Khaled Alswat, Taif University, Saudi Arabia
 
Our special thanks to the editors of  Journal of Diabetes & Metabolism, Pancreatic Disorders & Therapy and Journal of Steroids & Hormonal Science and the organizing committee members, Chair and Co-Chairs for their immense support and beneficial approach
 
Let us meet again in Global Diabetes 2016 in Birmingham, UK
 

 


Past Reports  Gallery  

Key Topics

  • Acupuncture for Diabetes
  • Alpha cells
  • Anti-diabetic Drugs
  • Artificial Pumps
  • Bariatric Surgery
  • Beta cells
  • Body Mass Index
  • Complementary and Alternative Medicine Therapies
  • Diabetes Physiology
  • Diabetes Epidemiology
  • Diabetic Dyslipidemia
  • Diabetic Gastroparesis
  • Diabetic Foot
  • Diabetic Kidney
  • Diabetic Mastopathy
  • Diabetic myelopathy
  • Diabetic nephropathy marker
  • Diabetic Neuropathy
  • Diabetic Retinopathy
  • Endocrine Disorder
  • Gestational Diabetes
  • Glucose Monitoring
  • Glucose pumps and sensors
  • Glucose Sensors
  • Hormone Replacement Therapy
  • Hypoglycemia
  • Insulin Pens
  • Insulin Pumps
  • Insulin Resistance
  • Latent Autoimmune Diabetes of Adults
  • Macrovascular Complications
  • Mind Body Medicine
  • Novel Insulin Delivery
  • Obesity
  • Pancreatic Islet Transplantation
  • Pathogenesis of Diabetes
  • Pathophysiology of Hypoglycemia
  • Peripheral Vascular Disease
  • Personalized Medicine
  • Rodent Model of Diabetes
  • Smart Insulin
  • Timesulin
  • Type 1 Diabetes
  • Type 2 Diabetes

Click here to submit abstract to any of the above topics

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 08-10, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations